USFDA concludes inspection at Solara Active Pharma Sciences Vizag facility with Zero 483 inspectional observations
We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok